haloperidol has been researched along with Cortical Lewy Body Disease in 6 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Malignant catatonia is a life-threatening syndrome, associated mostly with psychiatric diseases but also with neurological and neurodegenerative syndromes." | 1.56 | [Malignant catatonia in dementia with Lewy Body successfully treated with sismotherapy: A case report]. ( Dhote, J; Gasnier, M; Kipman, A, 2020) |
| "Suspecting neuroleptic malignant syndrome, dantrolene sodium was administered along with symptomatic treatment with mechanical ventilation and cooling." | 1.42 | [A Case of Neuroleptic Malignant Syndrome Associated with Undiagnosed Dementia with Lewy Bodies]. ( Fukuda, M; Komasawa, N; Minami, T; Nishihara, I; Oka, M, 2015) |
| "Bromperidol 12 mg was prescribed to treat his symptoms." | 1.31 | [Malignant syndrome caused by a combination of bromperidol and donepezil hydrochloride in a patient with probable dementia with Lewy bodies]. ( Iwado, H; Morita, Y; Shinjo, H; Ueki, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dhote, J | 1 |
| Kipman, A | 1 |
| Gasnier, M | 1 |
| Politis, AM | 1 |
| Kokras, N | 1 |
| Pappa, D | 1 |
| Siarkos, C | 1 |
| Katirtzoglou, E | 1 |
| Papadimitriou, GN | 1 |
| Kahn, DA | 1 |
| Oka, M | 1 |
| Komasawa, N | 1 |
| Nishihara, I | 1 |
| Fukuda, M | 1 |
| Minami, T | 1 |
| Schuster, JP | 1 |
| Buhl, C | 1 |
| Archambaud, F | 1 |
| Hardy, P | 1 |
| Chouinard, G | 1 |
| Prigent, A | 1 |
| Corruble, E | 1 |
| Chou, KL | 1 |
| Borek, LL | 1 |
| Friedman, JH | 1 |
| Ueki, A | 1 |
| Iwado, H | 1 |
| Shinjo, H | 1 |
| Morita, Y | 1 |
1 review available for haloperidol and Cortical Lewy Body Disease
| Article | Year |
|---|---|
The management of psychosis in movement disorder patients.
Topics: Antipsychotic Agents; Clozapine; Haloperidol; Humans; Huntington Disease; Lewy Body Disease; Parkins | 2007 |
5 other studies available for haloperidol and Cortical Lewy Body Disease
| Article | Year |
|---|---|
[Malignant catatonia in dementia with Lewy Body successfully treated with sismotherapy: A case report].
Topics: Aged; Antipsychotic Agents; Catatonia; Critical Care; Delusions; Depressive Disorder, Major; Electro | 2020 |
A severe and irreversible case of tardive rigid-akinetic parkinsonian syndrome: the role of the DaTscan.
Topics: Aged, 80 and over; Antipsychotic Agents; Brain; Diagnosis, Differential; Dopamine Plasma Membrane Tr | 2013 |
[A Case of Neuroleptic Malignant Syndrome Associated with Undiagnosed Dementia with Lewy Bodies].
Topics: Aged; Female; Haloperidol; Humans; Lewy Body Disease; Neuroleptic Malignant Syndrome; Treatment Outc | 2015 |
Using striatal dopamine transporter single photon emission computed tomography imaging to rule out Dementia with Lewy Bodies in elderly patients with antipsychotic-induced parkinsonism.
Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depressive Diso | 2007 |
[Malignant syndrome caused by a combination of bromperidol and donepezil hydrochloride in a patient with probable dementia with Lewy bodies].
Topics: Aged; Donepezil; Drug Therapy, Combination; Hallucinations; Haloperidol; Humans; Indans; Lewy Body D | 2001 |